Steiglitz, 2004 - Google Patents
Control of extracellular matrix biosynthesis by the bone morphogenetic protein-1/Tolloid-like metalloproteinasesSteiglitz, 2004
- Document ID
- 9141655598804399480
- Author
- Steiglitz B
- Publication year
External Links
Snippet
The vertebrate extracellular matrix (ECM) maintains tissue integrity and provides a substratum that contributes to activities such as cellular differentiation and migration during embryonic development and in adult organisms. The major ECM components, collagen …
- 102000001767 Tolloid-Like Metalloproteinases 0 title abstract description 106
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Miyama et al. | A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction | |
| Scott et al. | Mammalian BMP-1/Tolloid-related metalloproteinases, including novel family member mammalian Tolloid-like 2, have differential enzymatic activities and distributions of expression relevant to patterning and skeletogenesis | |
| US6464983B1 (en) | Methods and uses of connective tissue growth factor for differentiation of mesenchymal stem cells | |
| AU722919B2 (en) | Methods and uses of connective tissue growth factor as an induction agent | |
| Nakayama et al. | A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages | |
| Joliot et al. | a-2, 8-Polysialic acid is the neuronal surface receptor of Antennapedia homeobox peptide | |
| CA2179029C (en) | Vertebrate embryonic pattern-inducing hedgehog-like proteins | |
| US7144732B2 (en) | Vertebrate embryonic pattern-inducing proteins and uses related thereto | |
| US6607913B1 (en) | Vertebrate embryonic pattern-inducing proteins and uses related thereto | |
| JPH08503198A (en) | OP-3 induced morphogenesis | |
| JP2012213406A (en) | Nucleotide sequence and protein sequence of nogo gene, and method based thereon | |
| JP4083810B2 (en) | Hedgehog-interacting protein and related uses | |
| WO1998020029A2 (en) | Hnf3-delta compositions | |
| JPH11510054A (en) | Methods and compositions for identifying morphogen analogs | |
| JPH11510387A (en) | Methods and compositions for identifying morphogen analogs | |
| JP2000506373A (en) | TGFβ signaling proteins, genes and uses thereof | |
| US6165748A (en) | Frazzled nucleotide sequences and expression products | |
| US6635616B2 (en) | Laminin 15 | |
| JPH08510647A (en) | Cloning, expression and use of Dorsalin-1 | |
| Steiglitz | Control of extracellular matrix biosynthesis by the bone morphogenetic protein-1/Tolloid-like metalloproteinases | |
| WO1998022504A1 (en) | Novel semaphorin genes (i) | |
| Iyama et al. | Differential expression of two exons of the α1 (XI) collagen gene (Col11a1) in the mouse embryo | |
| JP2001517092A (en) | Modulators of morphogen expression and methods for identifying modulators | |
| JP2005154399A (en) | Use of serine protease HtrA | |
| Scott et al. | Timothy G. Clark,* Barry M. Steiglitz,‡ Christina L. Thomas,‡ Sarah A. Maas,‡ Kazuhiko Takahara,* Ken WY Cho,† and Daniel S. Greenspan |